News

Clinical study “PREV-HAP” submitted for approval

30/10/20

The Clinical Trial Application for the PREV-HAP study: “Human recombinant interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a double-blind, international, phase 2, randomized, placebo-controlled trial – the PREV-HAP study“, has been submitted by CHU-Nantes for approval to the regulatory authorities (France, Spain and Greece).

Next steps:

We expect an approval or a list of queries on the submitted documents by 30.11.2020, and aim to complete the VHP procedure by the end of the year.

News & Events

Wedata’s avatars solution certified by the French Data Protection Authority

30/10/20

See more

PREV-HAP investigators’ meeting

24/11/20

See more

HAP2 leaflet now available

30/10/20

This leaflet contains a concise overview of the project’s concept and objectives; the presentation of two clinical trials conducted within the project; and highlights the various outputs we will offer to patients...

See more